Abstract
Objectives: To assess the utility of lycopene, selenium, and vitamin E in the management of leukoplakia. Materials and Methods: In this cross-sectional observational prospective study, 52 patients of oral leukoplakia were divided into 2 groups. Group I patients were prescribed 6 mg of lycopene, 400 I.U. of vitamin E, and 200 μg of selenium twice a day. Group II patients were prescribed a placebo capsule. The clinical improvement was recorded in both groups. Results: The mean pretreatment size of lesion in group I was 9.24 cm 2 and in group II was 8.52 cm 2. Post treatment size was 1.52 cm 2 in group I and 6.28 cm 2 in group II. There was a significant reduction in the size of lesion in group I compared to group II (P < 0.05). Conclusion: The treatment with a combination of lycopene, selenium, and vitamin E is useful and effective in managing the cases of oral leukoplakia.
| Original language | English |
|---|---|
| Pages (from-to) | S233-S235 |
| Journal | Journal of Pharmacy and Bioallied Sciences |
| Volume | 14 |
| Issue number | 5 |
| DOIs | |
| State | Published - Jul 2022 |
Keywords
- Lycopene
- oral leukoplakia
- selenium
- vitamin E
Fingerprint
Dive into the research topics of 'Assessment of utility of lycopene, selenium, and Vitamin e in management of oral leukoplakia'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver